 
EUSFTA Annex 2-C - 1 
ANNEX 2-C 
 
 
PHARMACEUTICAL PRODUCTS AND MEDICAL DEVICES 
 
 
ARTICLE 1 
 
General Provisions 
 
The Parties confirm the following shared objectives and principles of: 
 
(a) 
preventing and eliminating non-tariff barriers to bilateral trade; 
 
(b) 
establishing competitive market conditions based on principles of openness, 
non-discrimination and transparency; 
 
(c) 
promoting innovation relating to safe and effective pharmaceutical products and 
medical devices, and promoting timely access to such pharmaceutical products and 
medical devices, through transparent and accountable procedures, without impeding 
a Party's ability to apply high standards of safety, efficacy and quality; and  
 
 
EUSFTA Annex 2-C - 2 
(d) 
enhancing cooperation between their respective health authorities, based on 
international standards, practices and guidelines within the framework of relevant 
international organisations such as the World Health Organization (hereinafter 
referred to as "WHO"), the Organisation for Economic Co-operation and Development 
(hereinafter referred to as "OECD"), the International Conference on Harmonisation 
(hereinafter referred to as "ICH"), the Pharmaceutical Inspection Convention and 
Pharmaceutical Inspection Co-operation Scheme (hereinafter referred to as "PIC/S") 
for pharmaceutical products and the Global Harmonization Task Force (hereinafter 
referred to as "GHTF") for medical devices. 
 
 
ARTICLE 2 
 
International Standards 
 
The Parties shall base their technical regulations on international standards, practices and 
guidelines for pharmaceutical products and medical devices, including those developed by 
the WHO, the OECD, the ICH, the PIC/S and the GHTF, unless there are substantiated 
reasons based on scientific or technical information why such international standards, 
practices or guidelines would be ineffective or inappropriate for the fulfilment of legitimate 
objectives pursued. 
 
 
 
